Diagnamed Holdings Corp. (DMED.CN)
CAD 0.03
(20.0%)
CAD 0.03
(20.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -1.06 Million | -787.58 Thousand | -565.59 Thousand |
| Net Income | -1.27 Million | -1.13 Million | -1.94 Million |
| Depreciation & Amortization | - | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 10.35 Thousand | 138.75 Thousand | - |
| Change in working capital | 150.26 Thousand | 206.1 Thousand | 118.07 Thousand |
| Other non-cash items | 49.8 Thousand | 151.92 Thousand | 1.26 Million |
| Investing Cash Flow | - | - | 34.06 Thousand |
| Investments in PPE | - | - | - |
| Acquisitions | - | - | 34.06 Thousand |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | - |
| Financing Cash Flow | 104.25 Thousand | - | 2.88 Million |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 104.25 Thousand | - | 2.88 Million |
| Other Financing Activities | 104.25 | - | 2889.34 |
| Accounts receivables | -9966.00 | -13.16 Thousand | -32.17 Thousand |
| Accounts payables | - | - | - |
| Inventory | - | - | - |
| Other working capital | 160.22 Thousand | 219.26 Thousand | 150.24 Thousand |
| Cash at beginning of period | 1.57 Million | 2.35 Million | - |
| Cash at end of period | 606.96 Thousand | 1.57 Million | 2.35 Million |
| Capital Expenditure | - | - | - |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -963.26 Thousand | -787.58 Thousand | 2.35 Million |
| Free Cash Flow | -1.06 Million | -787.58 Thousand | -565.59 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -220.62 Thousand | -126.61 Thousand | 39.86 Thousand | -1.27 Million | -302.64 Thousand | -193.6 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 10.35 Thousand | - | -409.00 |
| Change in working capital | 11.27 Thousand | 125.28 Thousand | -13.9 Thousand | 150.26 Thousand | 140.01 Thousand | -18.63 Thousand |
| Other non-cash items | 13.13 Thousand | -150.76 Thousand | -137.79 Thousand | 49.8 Thousand | -53.55 Thousand | 15.52 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | 104.25 Thousand | - | 83 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 104.25 Thousand | - | 83 Thousand |
| Other Financing Activities | - | - | - | 104.25 | - | 83.00 |
| Accounts receivables | -13.13 Thousand | 68.82 Thousand | -30 Thousand | -9966.00 | -18.47 Thousand | -15.52 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 24.41 Thousand | 56.46 Thousand | 16.09 Thousand | 160.22 Thousand | 158.49 Thousand | -3112.00 |
| Cash at beginning of period | 381.84 Thousand | 465.12 Thousand | 606.96 Thousand | 1.57 Million | 823.14 Thousand | 952.78 Thousand |
| Cash at end of period | 172.5 Thousand | 381.84 Thousand | 465.12 Thousand | 606.96 Thousand | 606.96 Thousand | 823.14 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -209.34 Thousand | -83.27 Thousand | -141.84 Thousand | -963.26 Thousand | -216.17 Thousand | -129.64 Thousand |
| Free Cash Flow | -209.34 Thousand | -83.27 Thousand | -141.84 Thousand | -1.06 Million | -216.17 Thousand | -212.64 Thousand |
EPIT
SCRSF
300243
VKAL
3678
4290